Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation
D. McCarty, A. Robinson
semanticscholar +1 more source
The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases. [PDF]
Hamada S +7 more
europepmc +1 more source
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors. [PDF]
Hays WB +6 more
europepmc +1 more source
Orally active factor Xa inhibitors: 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine derivatives
Noriyasu Haginoya +5 more
openalex +1 more source
L. Robertson, P. Kesteven, J. McCaslin
semanticscholar +1 more source
Less Is More: Microvascular Thrombophylaxis With Factor-Xa Inhibitor Monotherapy
Vikas S. Kotha +4 more
openalex +1 more source
Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial. [PDF]
Hamulyák EN +12 more
europepmc +1 more source
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair. [PDF]
Salazar CA +4 more
europepmc +1 more source
Investigation on the mechanisms of action of aprotinin in cardiac surgery [PDF]
Baranky, A. +8 more
core +1 more source
Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal
W. H. Dzik
semanticscholar +1 more source

